Volodymyr Ahunovych, Anton A. Klipkov, Maksym Bugera, Karen Tarasenko, Serhii Trofymchuk, Bohdan Razhyk, Andrii Boretskyi, Oleh Stanko, Yaroslav Panasiuk, Oleh Shablykin, Galeb Al-Maali, Dmytro Lesyk, Oleksii Klymenko-Ulianov, Kateryna Horbatok, Iryna Bodenchuk, Viktoriia Kosach, Petro Borysko, Vladimir Kubyshkin and Pavel K. Mykhailiuk*,
{"title":"CF3-环丁烷:作为独特的叔丁基类似物的合成、性质和评估","authors":"Volodymyr Ahunovych, Anton A. Klipkov, Maksym Bugera, Karen Tarasenko, Serhii Trofymchuk, Bohdan Razhyk, Andrii Boretskyi, Oleh Stanko, Yaroslav Panasiuk, Oleh Shablykin, Galeb Al-Maali, Dmytro Lesyk, Oleksii Klymenko-Ulianov, Kateryna Horbatok, Iryna Bodenchuk, Viktoriia Kosach, Petro Borysko, Vladimir Kubyshkin and Pavel K. Mykhailiuk*, ","doi":"10.1021/jacsau.4c0086410.1021/jacsau.4c00864","DOIUrl":null,"url":null,"abstract":"<p >Isosteric replacement of functional groups is an emerging strategy for optimizing bioactive molecules in drug discovery. <i>tert</i>-Butyl group is a particularly important moiety, yet its isosteric replacement with 1-trifluoromethyl-cyclobutyl group has been rather neglected. To enable the advance of this molecular fragment in drug discovery programs, we report the synthesis of over 30 small-molecule building blocks featuring the trifluoromethyl-cyclobutyl fragment, achieved by reacting sulfur tetrafluoride with cyclobutylcarboxylic acids on a gram-to-multigram scale. Furthermore, we characterized the structural properties of this group through X-ray analysis, studied its effect on acid–base transitions, and evaluated its Hammett parameters. Finally, we evaluated the replacement of <i>tert</i>-butyl with 1-trifluoromethyl-cyclobutyl in several bioactive compounds that represent commercial drugs and agrochemicals. Our findings indicate that while the trifluoromethyl-cyclobutyl group exhibited slightly larger steric size and moderately increased lipophilicity, it preserved the original mode of bioactivity in the examined cases and, in some cases, enhanced resistance to metabolic clearance.</p>","PeriodicalId":94060,"journal":{"name":"JACS Au","volume":"4 11","pages":"4507–4517 4507–4517"},"PeriodicalIF":8.5000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/epdf/10.1021/jacsau.4c00864","citationCount":"0","resultStr":"{\"title\":\"CF3-Cyclobutanes: Synthesis, Properties, and Evaluation as a Unique tert-Butyl Group Analogue\",\"authors\":\"Volodymyr Ahunovych, Anton A. Klipkov, Maksym Bugera, Karen Tarasenko, Serhii Trofymchuk, Bohdan Razhyk, Andrii Boretskyi, Oleh Stanko, Yaroslav Panasiuk, Oleh Shablykin, Galeb Al-Maali, Dmytro Lesyk, Oleksii Klymenko-Ulianov, Kateryna Horbatok, Iryna Bodenchuk, Viktoriia Kosach, Petro Borysko, Vladimir Kubyshkin and Pavel K. Mykhailiuk*, \",\"doi\":\"10.1021/jacsau.4c0086410.1021/jacsau.4c00864\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Isosteric replacement of functional groups is an emerging strategy for optimizing bioactive molecules in drug discovery. <i>tert</i>-Butyl group is a particularly important moiety, yet its isosteric replacement with 1-trifluoromethyl-cyclobutyl group has been rather neglected. To enable the advance of this molecular fragment in drug discovery programs, we report the synthesis of over 30 small-molecule building blocks featuring the trifluoromethyl-cyclobutyl fragment, achieved by reacting sulfur tetrafluoride with cyclobutylcarboxylic acids on a gram-to-multigram scale. Furthermore, we characterized the structural properties of this group through X-ray analysis, studied its effect on acid–base transitions, and evaluated its Hammett parameters. Finally, we evaluated the replacement of <i>tert</i>-butyl with 1-trifluoromethyl-cyclobutyl in several bioactive compounds that represent commercial drugs and agrochemicals. Our findings indicate that while the trifluoromethyl-cyclobutyl group exhibited slightly larger steric size and moderately increased lipophilicity, it preserved the original mode of bioactivity in the examined cases and, in some cases, enhanced resistance to metabolic clearance.</p>\",\"PeriodicalId\":94060,\"journal\":{\"name\":\"JACS Au\",\"volume\":\"4 11\",\"pages\":\"4507–4517 4507–4517\"},\"PeriodicalIF\":8.5000,\"publicationDate\":\"2024-11-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://pubs.acs.org/doi/epdf/10.1021/jacsau.4c00864\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACS Au\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/jacsau.4c00864\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACS Au","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/jacsau.4c00864","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
摘要
叔丁基是一个特别重要的分子基团,但用 1-三氟甲基环丁基对其进行同系物置换却一直被忽视。为了推动这一分子片段在药物发现计划中的应用,我们报告了 30 多种以三氟甲基环丁基片段为特征的小分子构筑基块的合成情况,这些小分子构筑基块是通过四氟化硫与环丁基羧酸的反应以克到毫克的规模合成的。此外,我们还通过 X 射线分析鉴定了该基团的结构特性,研究了其对酸碱转换的影响,并评估了其哈米特参数。最后,我们评估了在代表商业药物和农用化学品的几种生物活性化合物中用 1-三氟甲基环丁基取代叔丁基的情况。我们的研究结果表明,虽然三氟甲基环丁基的立体尺寸稍大,亲油性也适度增加,但在所研究的情况下,它保持了原有的生物活性模式,在某些情况下,还增强了抗代谢清除能力。
CF3-Cyclobutanes: Synthesis, Properties, and Evaluation as a Unique tert-Butyl Group Analogue
Isosteric replacement of functional groups is an emerging strategy for optimizing bioactive molecules in drug discovery. tert-Butyl group is a particularly important moiety, yet its isosteric replacement with 1-trifluoromethyl-cyclobutyl group has been rather neglected. To enable the advance of this molecular fragment in drug discovery programs, we report the synthesis of over 30 small-molecule building blocks featuring the trifluoromethyl-cyclobutyl fragment, achieved by reacting sulfur tetrafluoride with cyclobutylcarboxylic acids on a gram-to-multigram scale. Furthermore, we characterized the structural properties of this group through X-ray analysis, studied its effect on acid–base transitions, and evaluated its Hammett parameters. Finally, we evaluated the replacement of tert-butyl with 1-trifluoromethyl-cyclobutyl in several bioactive compounds that represent commercial drugs and agrochemicals. Our findings indicate that while the trifluoromethyl-cyclobutyl group exhibited slightly larger steric size and moderately increased lipophilicity, it preserved the original mode of bioactivity in the examined cases and, in some cases, enhanced resistance to metabolic clearance.